Dr. Mair talks about why breaking the transmission cycle by focusing on mosquitoes will help reduce global malaria, how a multi-pronged approach is necessary to eradicate this disease, how public health efforts coordinating drug administration have been effective, and some of the hurdles that impede vaccine development.

Published in microTalk

To eliminate malaria, you have to stop transmission. Carolina Barillas-Mury discusses the co-evolution of malaria, mosquitos, and man.

Sunday, 16 September 2018 15:39

Accessory found guilty in DC - TWiV 511

Ned Landau joins the TWiV team to discuss restriction of HIV replication by SAMHD1, and a viral antagonist that can be used to produce a dendritic cell vaccine.

Published in TWiV

The ongoing outbreak of Ebola virus in the Democratic Republic of the Congo, and the finding that mutations identified in the 2015 West African epidemic do not alter pathogenesis in animals. 

Published in TWiV

Recent mumps virus outbreaks in the US are due to waning vaccine efficacy, and an intranasally delivered small interfering RNA that controls West Nile infection in the brain.

Published in TWiV
Thursday, 08 February 2018 00:07

Rats, lice, and nanoparticles - TWiM 170

The spread of plague was likely due to human ectoparasites, not rats, and discussion of a durable, broadly protective protein nanoparticle influenza virus vaccine.

Published in TWiM
Sunday, 10 December 2017 16:15

Songs of innocence and experience - TWiV 471

Restriction of dengue virus vaccine by Sanofi, and data which suggest that Dengvaxia causes enhanced disease in previously uninfected recipients

Published in TWiV

Stacey Schultz-Cherry explains the selection process to choose the influenza virus strains to include in the annual influenza vaccine.

Monday, 28 August 2017 15:55

Siderophores: A treatment target?

Siderophores are essential for bacterial pathogenesis—does that make them a weakness for researchers to exploit?

Published in Microbial Sciences

At the University of Maryland, Baltimore, researchers are using a practical method, bacterial enzymatic combinatorial chemistry (BECC), to generate functionally diverse molecules that can potentially be used as adjuvants.

Published in mBiosphere
Page 1 of 2

TPL_asm2013_SEARCH